Clinical guidelines for the treatment of depressive disorders. II. Principles of management
- PMID: 11441769
Clinical guidelines for the treatment of depressive disorders. II. Principles of management
Abstract
Background: The Canadian Psychiatric Association and the Canadian Network for Mood and Anxiety Treatments partnered to produce clinical guidelines for psychiatrists for the treatment of depressive disorders.
Methods: A standard guidelines development process was followed. Relevant literature was identified using a computerized Medline search supplemented by review of bibliographies. Operational criteria were used to rate the quality of scientific evidence, and the line of treatment recommendations included consensus clinical opinion. This section on "Principles of Management" is 1 of 7 articles drafted and reviewed by clinicians. Revised drafts underwent national and international expert peer review.
Results: The principles and goals of psychiatric management with psychotherapy and pharmacotherapy are reviewed. Two phases of treatment, acute and maintenance, are identified. Special topics, including inpatient management, suicide management, and medical-legal issues are also discussed.
Conclusions: These principles of psychiatric management provide a framework for the use of specific treatments for depressive disorders.
Similar articles
-
Clinical guidelines for the treatment of depressive disorders, I. Definitions, prevalence, and health burden.Can J Psychiatry. 2001 Jun;46 Suppl 1:13S-20S. Can J Psychiatry. 2001. PMID: 11441768
-
Clinical guidelines for the treatment of depressive disorders. V. Combining psychotherapy and pharmacotherapy.Can J Psychiatry. 2001 Jun;46 Suppl 1:59S-62S. Can J Psychiatry. 2001. PMID: 11441772
-
Clinical guidelines for the treatment of depressive disorders. VII. Comorbidity.Can J Psychiatry. 2001 Jun;46 Suppl 1:77S-90S. Can J Psychiatry. 2001. PMID: 11441774 Review.
-
Clinical guidelines for the treatment of depressive disorders. VI. Special populations.Can J Psychiatry. 2001 Jun;46 Suppl 1:63S-76S. Can J Psychiatry. 2001. PMID: 11441773 Review.
-
Clinical guidelines for the treatment of depressive disorders. IV. Medications and other biological treatments.Can J Psychiatry. 2001 Jun;46 Suppl 1:38S-58S. Can J Psychiatry. 2001. PMID: 11441771 Review.
Cited by
-
HPA axis activation determined by the CRH challenge test in patients with few versus multiple episodes of treatment-refractory depression.Eur Arch Psychiatry Clin Neurosci. 2004 Dec;254(6):349-55. doi: 10.1007/s00406-004-0512-3. Epub 2004 Nov 12. Eur Arch Psychiatry Clin Neurosci. 2004. PMID: 15538608 Clinical Trial.
-
An evaluation of the quick inventory of depressive symptomatology and the hamilton rating scale for depression: a sequenced treatment alternatives to relieve depression trial report.Biol Psychiatry. 2006 Mar 15;59(6):493-501. doi: 10.1016/j.biopsych.2005.08.022. Epub 2005 Sep 30. Biol Psychiatry. 2006. PMID: 16199008 Free PMC article. Clinical Trial.
-
The clinical pharmacology of depressive states.Dialogues Clin Neurosci. 2002 Mar;4(1):47-56. doi: 10.31887/DCNS.2002.4.1/pschulz. Dialogues Clin Neurosci. 2002. PMID: 22034133 Free PMC article.
-
The Korean Medication Algorithm Project for Depressive Disorder 2021: Comparisons with Other Treatment Guidelines.Clin Psychopharmacol Neurosci. 2022 Feb 28;20(1):37-50. doi: 10.9758/cpn.2022.20.1.37. Clin Psychopharmacol Neurosci. 2022. PMID: 35078947 Free PMC article. Review.
-
What Are the Implications of the STAR*D Trial for Primary Care? A Review and Synthesis.Prim Care Companion J Clin Psychiatry. 2008;10(2):91-6. doi: 10.4088/pcc.v10n0201. Prim Care Companion J Clin Psychiatry. 2008. PMID: 18458732 Free PMC article.